Translational Mini-Review Series on Vaccines for HIV: Harnessing innate immunity for HIV vaccine development

Innate immunity is critical for shaping vaccine-elicited adaptive immune responses. Several classes of immune sensors, including Toll-like receptors, retinoic acid-inducible gene-I-like receptors, nucleotide-binding oligomerization domain-like receptors and cytosolic DNA receptors mediate important...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental immunology Vol. 157; no. 2; pp. 174 - 180
Main Authors Rhee, E.G, Barouch, D.H
Format Journal Article
LanguageEnglish
Published Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.08.2009
Blackwell Publishing Ltd
Blackwell
Blackwell Science Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Innate immunity is critical for shaping vaccine-elicited adaptive immune responses. Several classes of immune sensors, including Toll-like receptors, retinoic acid-inducible gene-I-like receptors, nucleotide-binding oligomerization domain-like receptors and cytosolic DNA receptors mediate important innate immune pathways and provide potential targets for novel adjuvant development. Understanding how innate immunity modulates adaptive immune responses will probably be important for optimizing vaccine candidates. Here, we review recent advances in innate immunity, focusing upon their potential applications in developing adjuvants and vectors for HIV vaccines.
Bibliography:http://dx.doi.org/10.1111/j.1365-2249.2009.03928.x
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-3
ObjectType-Review-1
OTHER ARTICLE PUBLISHED IN THIS MINI-REVIEW SERIES ON VACCINES FOR HIV T lymphocyte trafficking and vaccine-elicited mucosal immunity. Clin Exp Immunol 2009; 157: doi:10.1111/j.1365-2249.2009.03927.x
ISSN:0009-9104
1365-2249
DOI:10.1111/j.1365-2249.2009.03928.x